India's Aurobindo Pharma drops on quarterly profit fall

Aurobindo Pharma

05/08/2025 10:54

** Shares of Aurobindo Pharma ARBN.NS fall as much as 2.7% to 1060.90 rupees

** Pharma co posts 10% y/y drop in June-qtr consol net PAT, expenses rise 5%

** ARBN rev rose 4% but missed analysts' expectations of Macquarie and Motilal Oswal

** Macquarie said revenue miss was driven by lower than expected revenue from the U.S. business

** Adds, muted growth in co's "bread and butter" U.S. business worrisome

** More than 2.5 mln shares traded, 2x their 30-day avg

** Stock last down 1%, taking YTD losses to 18%

 (Reporting by Nishit Navin in Bengaluru)

 ((nishit.navin@thomsonreuters.com))